VRX Related Hot List
-
Actavis (ACT) Said to be in Talks to Acquire Warner Chilcott (WCRX)
-
Cephalon (CEPH) Rejects Valeant's (VRX) $73/Share Offer
-
Valeant Pharma (VRX) proposes to buy Cephalon (CEPH) for $73 per share
-
S&P Announces Changes to Indices: BEZ for VRX in MidCap 400, UHT for BEZ in SmallCap 600
-
Valeant Pharma (VRX) Says FDA Accepts NDA Filing for Retigabine
-
Valeant Pharmaceuticals (VRX) Tops Q1 View By 14c; Raises Prior Guidance
-
Valeant Pharmaceuticals (VRX) Tops Q4 EPS by 10c
-
Valeant Pharmaceuticals (VRX) Said Viramidine Did Not Meet Efficacy Endpoint in Trial
-
Valeant Pharma (VRX) Announces Restructuring Plan; Sees Q1 Adj EPS Below Cons
-
Valeant Pharm (VRX) said VISER1 study did not meet the non-inferiority efficacy endpoint on an overall intent-to-treat basis
-
VRX Receives non-approvable letter from the FDA for changes to Cesamet
-
Think Equity Starts VRX at Sell
Back to VRX Stock Lookup
